MAPT and Alzheimer disease: While this review does not definitively assert that reactive astrocytes precede other pathological hallmarks such as amyloid and tau pathologies, it appropriately recognizes the antecedent appearance of reactive astrocytes in the progression of neurodegeneration (Fig. 1c) and emphasizes their pathological significance in the context of AD [22].